Journal Browser
Search
Initial results of magnetic resonance hysterosalpingography diagnostic performance
Andrés Alejandro Kohan
Mariana Cecilia Kucharczyk
Natalia T. Posadas
Noelia N. Napoli
Santiago Jose Gil
Nora Angélica Fuentes
Ricardo Daniel García-Mónaco
Carolina Rosa Beatriz Chacón
Imaging and Radiation Research 2022, 5(2), 51-58; https://doi.org/10.24294/irr.v5i2.1755
Submitted:01 Jan 1970
Accepted:01 Jan 1970
Published:01 Jan 1970
Abstract

Objective: to determine the diagnostic performance of magnetic resonance hysterosalpingography (HSG-MRI), using laparoscopy as the reference method. Materials and methods: 22 patients were included. All underwent HSG-MRI with a 1.5 Tesla resonator and then laparoscopy with chromotubation. Two radiologists examined the MRIs, determining tubal patency by consensus. Descriptive and diagnostic performance analyses were performed. Results: HSG-MRI had a success rate of 91%. Study duration was 49 ± 15 minutes, volume injected 26 ± 16 cm3 and pain scale 30 ± 19 out of 100. Sensitivity and specificity of HSG-MRI were 100% for global and left Cotte test, and 25% and 93.3% for right Cotte test, respectively. There were 2 minor complications and no major complications. Discussion: our initial results demonstrated high sensitivity and specificity. Although other studies analyzed the ability of HSG-MRI to assess tubal patency with good results, the use of a flawed reference standard left room for reasonable doubt, preventing a recommendation based on solid evidence. However, when comparing our results with those published, we observed a high degree of concordance insofar as the positive effusion is correctly diagnosed with a specificity of 100% or with a percentage close to this figure.

References
Frye RE, Ascher SM, Thomasson D. MR hysterosalpingography: Protocol development and refinement for simulating normal and abnormal fallopian tube patency-feasibility study with a phantom. Radiology 2000; 214: 107–112.
Krysiewicz S. Infertility in women: Diagnostic evaluation with hysterosalpingography and other imaging techniques. American Journal of Roentgenology 1992; 159: 253–261.
Imaoka I, Wada A, Matsuo M, et al. MR imaging of disorders associated with female infertility: Use in diagnosis, treatment, and management. Radiographics 2003; 23: 1401–1421.
Troiano RN, McCarthy SM. Mullerian duct anomalies: Imaging and clinical issues. Radiology 2004; 233: 19–34.
Woodward PJ, Wagner BJ, Farley TE. MR imaging in the evaluation of female infertility. Radiographics 1993; 13: 293–310.
Swart P, Mol BW, van der Veen F, et al. The accuracy of hysterosalpingography in the diagnosis of tubal pathology: A meta-analysis. Fertility and Sterility 1995; 64: 486–491.
Broeze KA, Opmeer BC, Van Geloven N, et al. Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis. Human Reproduction Update 2011; 17: 293–300.
De Felice C, Rech F, Marini A, et al. Magnetic resonance hysterosalpingography in the evaluation of tubal patency in infertile women: An observational study. Clinical and Experimental Obstetrics and Gynecology 2012; 39: 83–88.
Freeman-Walsh CB, Fahrig R, Ganguly A, et al. A hybrid radiography/MRI system for combining hysterosalpingography and MRI in infertility patients: Initial experience. American Journal of Roentgenology 2008; 190: W157–W160.
Furuhashi M, Miyabe Y, Katsumata Y, et al. Magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid is useful in assessment of tubal patency in a patient with iodine-induced hypothyroidism. Magnetic Resonance Imaging 1998; 16: 339–341.
Ma L, Wu G, Wang Y, et al. Fallopian tubal patency diagnosed by magnetic resonance hysterosalpin-gography. Journal of Reproductive Medicine 2012; 57: 435–440.
Sadowski EA, Ochsner JE, Riherd JM, et al. MR hysterosalpingography with an angiographic time-resolved 3D pulse sequence: assessment of tubal patency. American Journal of Roentgenology 2008; 191: 1381–1385.
Unterweger M, De Geyter C, Frohlich JM, et al. Three-dimensional dynamic MR-hysterosalpingography; A new, low invasive, radiation-free and less painful radiological approach to female infertility. Human Reproduction 2002; 17: 3138–3141.
Wiesner W, Ruehm SG, Bongartz G, et al. Three-dimensional dynamic MR hysterosalpingography: A preliminary report. European Radiology 2001; 11: 1439–1444.
Winter L, Glucker T, Steimann S, et al. Feasibility of dynamic MR-hysterosalpingography for the diagnostic work-up of infertile women. Acta Radiologica 2010; 51: 693–701.
Belt MM, Rodenko G, Taylor K, et al. Use of gadolinium for hysterosalpingography in iodine allergic women: A case-control study. Fertility and Sterility 2008; 90: 835–838.
De Caro G, Ferraiolo A, Castelletti L, et al. Hysterosalpingography with gadolinium. European Radiology 2005; 15: 1469–1471.
Silberzweig JE, Khorsandi AS, Caldon M, et al. Gadolinium for hysterosalpingography. Journal of Reproductive Medicine 2008; 53: 15–19.
Harpur ES, Worah D, Hals PA, et al. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Investigative Radiology 1993; 28(Suppl 1): S28–S43.
Rouanet De Lavit JP, Maubon AJ, Thurmond AS. MR hysterography performed with saline injection and fluid attenuated inversion recovery sequences: Initial experience. American Journal of Roentgenology 2000; 175: 774–776.
© 2025 by the EnPress Publisher, LLC. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Copyright © by EnPress Publisher. All rights reserved.

TOP